Subsequently, two normal controls, two PRR34‐AS1‐hypermethylated AML patients, and two PRR34‐AS1‐unmethylated AML patients were randomly selected to verify the MSP results through BSP (Figure 2C). This evidence concerns the gene PRR34 and acute myeloid leukemia.